KIT and neoplasm: The inhibition of c-kit using specific antibodies resulted in a noticeable decrease in the amount of myeloid-derived suppressor cells (MDSC) in the tumor microenvironment and significantly increased the antitumor activity of T cell checkpoint antibody-based inhibitors [102].